Stoke Therapeutics, Inc. STOK
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Thomas Shrader | BTIG | 18.1 $ | 28 $ | 9.90 % | 18/08/2025 |
| Marc Goodman | Leerink Partners | 11.84 $ | 18 $ | 6.16 % | 11/10/2024 |
| Debjit Chattopadhyay | H.C. Wainwright | 15.3201 $ | 35 $ | 19.68 % | 11/09/2024 |
| Sumant Kulkami | Canaccord Genuity | 11.87 $ | 20 $ | 8.13 % | 07/05/2024 |
| Joseph Stringer | Needham | 6.5 $ | 22 $ | 15.50 % | 26/03/2024 |
| Sumant Kulkami | Canaccord Genuity | 10.92 $ | 21 $ | 10.08 % | 26/03/2024 |
| Judah Frommer | Credit Suisse | 32.5 $ | 58 $ | 25.50 % | 26/04/2021 |